scispace - formally typeset
E

Emilie H. Zobel

Researcher at Steno Diabetes Center

Publications -  30
Citations -  549

Emilie H. Zobel is an academic researcher from Steno Diabetes Center. The author has contributed to research in topics: Type 2 diabetes & Liraglutide. The author has an hindex of 7, co-authored 23 publications receiving 294 citations.

Papers
More filters
Journal ArticleDOI

Global Changes in Food Supply and the Obesity Epidemic.

TL;DR: How a global shift in the food system caused by global economic growth, increase in available food per capita and in food processing is a driver of the obesity epidemic is explored.
Journal ArticleDOI

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY) : a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, +133 more
TL;DR: This study recruited people with type 2 diabetes, normal urinary albumin excretion, and preserved renal function from 15 specialist centres in ten European countries and tested whether a urinary proteomic risk classifier (CKD273) score was associated with development of microalbuminuria and whether progression to micro Albuminuria could be prevented with the mineralocorticoid receptor antagonist spironolactone.
Journal ArticleDOI

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

TL;DR: In persons with type 2 diabetes and microalbuminuria higher SDMA was associated with incident cardiovascular disease, all-cause mortality and deterioration in renal function and c statistics and relative integrated discrimination improvement (rIDI) significantly improved risk prediction for all- Cause mortality, and SDMA for deterioration in kidneys function beyond traditional risk factors.